loading
前日終値:
$12.57
開ける:
$12.58
24時間の取引高:
26,006
Relative Volume:
0.50
時価総額:
$272.72M
収益:
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
+3.25%
1か月 パフォーマンス:
-10.92%
6か月 パフォーマンス:
+0.00%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
Value
$11.55
$13.24
1週間の範囲:
Value
$11.50
$13.63
52週間の値動き範囲:
Value
$4.88
$19.58

Aardvark Therapeutics Inc Stock (AARD) Company Profile

Name
名前
Aardvark Therapeutics Inc
Name
セクター
Healthcare (1166)
Name
電話
(858) 225-7696
Name
住所
4370 LA JOLLA VILLAGE DRIVE, SAN DIEGO
Name
職員
26
Name
Twitter
Name
次回の収益日
Name
最新のSEC提出書
Name
AARD's Discussions on Twitter

AARD を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
AARD
Aardvark Therapeutics Inc
12.57 272.19M 0 0 0 0.00
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
376.99 96.11B 11.42B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
561.05 60.40B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
427.60 54.91B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
668.59 41.30B 3.05B 1.28B -614.78M 19.58
Biotechnology icon
ONC
Beone Medicines Ltd Adr
294.90 33.25B 3.81B -644.79M -669.77M -6.24

Aardvark Therapeutics Inc Stock (AARD) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-06-30 開始されました H.C. Wainwright Buy
2025-03-10 開始されました BofA Securities Buy
2025-03-10 開始されました Cantor Fitzgerald Overweight
2025-03-10 開始されました Morgan Stanley Overweight
2025-03-10 開始されました RBC Capital Mkts Outperform

Aardvark Therapeutics Inc (AARD) 最新ニュース

pulisher
07:58 AM

Is Aardvark Therapeutics Inc. meeting your algorithmic filter criteriaEquity Performance Forecast Based on AI Models - Newser

07:58 AM
pulisher
Aug 06, 2025

Technical signs of recovery in Aardvark Therapeutics Inc.Free Accurate Technical Trend Reversal Picks - Newser

Aug 06, 2025
pulisher
Aug 06, 2025

Moving Average Trends for Aardvark Therapeutics Inc. Stock: What They IndicateFree Community Verified Stock Suggestions - Newser

Aug 06, 2025
pulisher
Aug 06, 2025

Can machine learning forecast Aardvark Therapeutics Inc. recoveryFree Proven Entry Plan With Low Risk Trade - Newser

Aug 06, 2025
pulisher
Aug 06, 2025

Why Aardvark Therapeutics Inc. stock is on top investor watchlistsFree Triple Digit Return Stock Predictions - Newser

Aug 06, 2025
pulisher
Aug 05, 2025

Published on: 2025-08-05 19:48:37 - Newser

Aug 05, 2025
pulisher
Aug 05, 2025

News impact scoring models applied to Aardvark Therapeutics Inc.Free Fundamental + Technical Hybrid Stock Tips - Newser

Aug 05, 2025
pulisher
Aug 05, 2025

Aardvark Therapeutics, Inc.’s (NASDAQ:AARD) Lock-Up Period Set To Expire on August 12th - Defense World

Aug 05, 2025
pulisher
Aug 05, 2025

Combining price and volume data for Aardvark Therapeutics Inc.Free Capital Preserving Trade Plan Templates - Newser

Aug 05, 2025
pulisher
Aug 04, 2025

Volume spikes in Aardvark Therapeutics Inc. stock – what they meanFree Quick Gain Stock Watch With Indicators - Newser

Aug 04, 2025
pulisher
Aug 04, 2025

Why Aardvark Therapeutics Inc. stock attracts strong analyst attentionShort Term Gain Strategy with AI Logic - Newser

Aug 04, 2025
pulisher
Aug 04, 2025

What analysts say about Aardvark Therapeutics Inc. stockBuild wealth steadily with smart trading - Jammu Links News

Aug 04, 2025
pulisher
Aug 04, 2025

Evaluating Aardvark Therapeutics Inc. with trendline analysisWealth Accumulation Outlook for Safe Investors - Newser

Aug 04, 2025
pulisher
Aug 03, 2025

Why is Aardvark Therapeutics Inc. stock attracting strong analyst attentionUnlock daily market insights for better decisions - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Applying big data sentiment scoring on Aardvark Therapeutics Inc.Risk-Managed Trade Alerts for Consistency - newser.com

Aug 03, 2025
pulisher
Aug 03, 2025

What are the latest earnings results for Aardvark Therapeutics Inc.Consistent double returns - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Risk vs reward if holding onto Aardvark Therapeutics Inc.High Conviction Stock Long-Term Summary - newser.com

Aug 03, 2025
pulisher
Aug 03, 2025

Is Aardvark Therapeutics Inc. a good long term investmentInvest smarter with data-backed insights - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

How does Aardvark Therapeutics Inc. compare to its industry peersBuild a portfolio that outperforms the market - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

How does Aardvark Therapeutics Inc. generate profit in a changing economyDiscover investment plans that deliver results - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What makes Aardvark Therapeutics Inc. stock price move sharplyAchieve breakthrough financial results - Jammu Links News

Aug 03, 2025
pulisher
Aug 02, 2025

What are analysts’ price targets for Aardvark Therapeutics Inc. in the next 12 monthsUnmatched profit potential - Jammu Links News

Aug 02, 2025
pulisher
Aug 02, 2025

Published on: 2025-08-03 04:04:58 - Jammu Links News

Aug 02, 2025
pulisher
Aug 02, 2025

Reversal indicators forming on Aardvark Therapeutics Inc. stockSmart Stock Forecast Using AI Algorithms - Newser

Aug 02, 2025
pulisher
Aug 02, 2025

Strategies to average down on Aardvark Therapeutics Inc.Free Risk-Adjusted Picks With Exit Strategy - Newser

Aug 02, 2025
pulisher
Aug 01, 2025

Earnings visualization tools for Aardvark Therapeutics Inc.Daily Pick Forecast with Entry Zones - Newser

Aug 01, 2025
pulisher
Aug 01, 2025

What’s next for Aardvark Therapeutics Inc. stock priceEarnings Impact and Stock Reaction Analysis - Newser

Aug 01, 2025
pulisher
Jul 31, 2025

Sector ETF performance correlation with Aardvark Therapeutics Inc.Breakout Entry Signal Confirmation Tool Used - metal.it

Jul 31, 2025
pulisher
Jul 31, 2025

Published on: 2025-07-30 23:36:06 - Newser

Jul 31, 2025

Aardvark Therapeutics Inc (AARD) 財務データ

Aardvark Therapeutics Inc (AARD) の財務データはありません。詳細については、他の銘柄を確認してください。

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Aardvark Therapeutics Inc (AARD) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
Lee Tien-Li
Chief Executive Officer
Feb 14 '25
Buy
16.00
16,542
264,672
1,496,175
Sun Nelson
Chief Financial Officer
Feb 14 '25
Buy
16.00
10,000
160,000
99,484
Cormorant Asset Management, LP
Former 10% Owner
Feb 14 '25
Buy
16.00
187,500
3,000,000
987,689
$77.24
price down icon 0.53%
$36.81
price down icon 0.74%
$108.42
price down icon 2.99%
$27.62
price down icon 3.37%
$111.33
price up icon 0.00%
biotechnology ONC
$294.90
price down icon 1.33%
大文字化:     |  ボリューム (24 時間):